Northern Trust’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4K | Hold |
54,977
| – | – | ﹤0.01% | 4356 |
|
|
2025
Q1 | $17K | Hold |
54,977
| – | – | ﹤0.01% | 4352 |
|
|
2024
Q4 | $41.2K | Hold |
54,977
| – | – | ﹤0.01% | 4286 |
|
|
2024
Q3 | $68.7K | Hold |
54,977
| – | – | ﹤0.01% | 4142 |
|
|
2024
Q2 | $68.7K | Sell |
54,977
-49
| -0.1% | -$61 | ﹤0.01% | 4140 |
|
|
2024
Q1 | $61.6K | Sell |
55,026
-224
| -0.4% | -$251 | ﹤0.01% | 4189 |
|
|
2023
Q4 | $73.5K | Hold |
55,250
| – | – | ﹤0.01% | 4166 |
|
|
2023
Q3 | $58.6K | Sell |
55,250
-737
| -1% | -$781 | ﹤0.01% | 4132 |
|
|
2023
Q2 | $62.1K | Sell |
55,987
-6,178
| -10% | -$6.86K | ﹤0.01% | 4160 |
|
|
2023
Q1 | $92K | Buy |
62,165
+563
| +0.9% | +$833 | ﹤0.01% | 4103 |
|
|
2022
Q4 | $155K | Buy |
61,602
+5,498
| +10% | +$13.9K | ﹤0.01% | 3964 |
|
|
2022
Q3 | $180K | Buy |
56,104
+5,220
| +10% | +$16.7K | ﹤0.01% | 3920 |
|
|
2022
Q2 | $286K | Buy |
50,884
+3,784
| +8% | +$21.3K | ﹤0.01% | 3739 |
|
|
2022
Q1 | $291K | Sell |
47,100
-1,513
| -3% | -$9.35K | ﹤0.01% | 3960 |
|
|
2021
Q4 | $434K | Sell |
48,613
-411
| -0.8% | -$3.67K | ﹤0.01% | 3865 |
|
|
2021
Q3 | $477K | Sell |
49,024
-736
| -1% | -$7.16K | ﹤0.01% | 3780 |
|
|
2021
Q2 | $410K | Sell |
49,760
-237,339
| -83% | -$1.96M | ﹤0.01% | 3802 |
|
|
2021
Q1 | $2.74M | Sell |
287,099
-19,377
| -6% | -$185K | ﹤0.01% | 3082 |
|
|
2020
Q4 | $2.85M | Buy |
306,476
+3,153
| +1% | +$29.3K | ﹤0.01% | 3000 |
|
|
2020
Q3 | $4.12M | Sell |
303,323
-4,212
| -1% | -$57.3K | ﹤0.01% | 2653 |
|
|
2020
Q2 | $5.95M | Buy |
307,535
+287,044
| +1,401% | +$5.55M | ﹤0.01% | 2408 |
|
|
2020
Q1 | $156K | Buy |
+20,491
| New | +$156K | ﹤0.01% | 3730 |
|